Fully Licensed & Contracted Absentee-Owned Pharmacy in Sumrall, MS

Description

Absentee-owned pharmacy for sale in Sumrall, Mississippi. The business was established in 2019 and currently fills an average of approximately 100 prescriptions per day.

Business profile

• Operating since 2019
• Approximately 100 prescriptions filled per day
• Absentee ownership structure
• Experienced pharmacy staff in place
• Existing PBM relationships
• Medicare and Medicaid participation

Operations

The pharmacy has an existing employee team handling daily operations. The seller states that staff members are expected to remain through the ownership transition, although continued employment should be confirmed individually.

Payer contracts

The pharmacy is represented as contracted with major Pharmacy Benefit Managers as well as Medicare and Medicaid.

These relationships are material to current prescription volume and reimbursement. Buyers should confirm credentialing, reimbursement terms and change-of-ownership requirements directly with each payer and PBM.

Inventory and compliance

The transaction is described as a clean stock sale. The seller reports no current audits or contract issues.

A buyer should independently review any pending PBM audits, recoupments, disciplinary matters or compliance issues before closing.

Growth

• Increase local prescription volume
• Develop relationships with nearby medical providers
• Expand permitted clinical or vaccination services
• Increase front-end retail sales
• Develop medication synchronization and delivery programs where appropriate

Due diligence

Buyers should verify prescription counts, payer mix, reimbursement rates, gross margin by drug category, inventory value, accounts receivable, staff compensation, pharmacist coverage, wholesaler agreements and historical financial statements.

Mississippi pharmacy licensing, DEA registration, controlled-substance compliance, Medicare and Medicaid enrollment, PBM agreements and patient records should not be assumed to transfer automatically. Appropriate regulatory and payer approvals should be confirmed before closing.